المؤلفون: Gao J; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Song Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Kou X; Department of Medical Oncology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, China., Tan Z; Department of Thoracic Surgery, Xingtai People's Hospital, Xingtai, China., Zhang S; Department of Gastrointestinal Oncology, Shandong First Medical University Cancer Hospital, Shandong Cancer Hospital, Jinan, China., Sun M; Department of Medical Oncology, Central Hospital Affiliated to Shandong First Medical University, Jinan, China., Zhou J; Department of Medical Oncology, Sichuan Cancer Hospital, Chengdu, China., Fan M; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China., Zhang M; Department of Integrated Traditional and Western Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China., Song Y; Department of Thoracic Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi, China., Li S; Department of Medical Oncology, Anhui Provincial Cancer Hospital, Hefei, China., Yuan Y; Department of Medical Oncology, Xuzhou Central Hospital, Xuzhou, China., Zhuang W; Department of Medical Oncology, Fujian Cancer Hospital, Fuzhou, China., Zhang J; Medical Oncology Department of Gastrointestinal Cancer, Liaoning Cancer Hospital & Institute, Cancer Hospital of China Medical University, Shenyang, China., Zhang L; Department of Oncology, Chongqing University Three Gorges Hospital, Chongqing, China., Jiang H; Department of Radiation Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China., Gu K; Department of Medical Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China., Ye H; Department of Medical Oncology, The First Affiliated Hospital of Xiamen University, Xiamen, China., Ke Y; Shanghai Henlius Biotech, Inc., Shanghai, China., Qi X; Shanghai Henlius Biotech, Inc., Shanghai, China., Wang Q; Shanghai Henlius Biotech, Inc., Shanghai, China., Zhu J; Shanghai Henlius Biotech, Inc., Shanghai, China., Huang J; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

المصدر: Cancer medicine [Cancer Med] 2024 May; Vol. 13 (10), pp. e7203.

نوع المنشور: Journal Article; Meta-Analysis

بيانات الدورية: Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE

مواضيع طبية MeSH: Liver Neoplasms*/secondary , Liver Neoplasms*/drug therapy , Liver Neoplasms*/mortality , Esophageal Squamous Cell Carcinoma*/drug therapy , Esophageal Squamous Cell Carcinoma*/secondary , Esophageal Squamous Cell Carcinoma*/mortality , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Esophageal Neoplasms*/drug therapy , Esophageal Neoplasms*/pathology , Esophageal Neoplasms*/mortality, Humans ; Male ; Immune Checkpoint Inhibitors/therapeutic use ; Female ; Middle Aged ; Randomized Controlled Trials as Topic ; Aged ; Treatment Outcome ; Antibodies, Monoclonal, Humanized/therapeutic use ; Antibodies, Monoclonal, Humanized/administration & dosage